Rankings
▼
Calendar
CRMD Q4 2017 Earnings — CorMedix Inc. Revenue & Financial Results | Market Cap Arena
CRMD
CorMedix Inc.
$518M
Q4 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$92,526
-24.0% YoY
Gross Profit
$29,215
31.6% margin
Operating Income
-$10M
-11100.2% margin
Net Income
-$10M
-11143.4% margin
EPS (Diluted)
$-0.77
QoQ Revenue Growth
+51.5%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$394,860
Balance Sheet
Total Assets
$13M
Total Liabilities
$6M
Stockholders' Equity
-$152M
Cash & Equivalents
$10M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$92,526
$121,715
-24.0%
Gross Profit
$29,215
$36,384
-19.7%
Operating Income
-$10M
-$6M
-59.7%
Net Income
-$10M
-$6M
-61.1%
← FY 2017
All Quarters
Q1 2018 →